Skip to content

Episode Notes

Source / episode info

  • Episode: 262
  • Title: Divine Intervention Episode 262 – The Clutch TB Podcast.
  • Published: 2020-09-18
  • Source: Episode page

One-liner

This episode provides a comprehensive review of tuberculosis management, covering the appropriate use of Tuberculin Skin Test (TST) versus Interferon Gamma Release Assay (IGRA), differentiating latent from active TB disease, managing MAC infections, and interpreting CSF findings in TB meningitis.

High-yield summary

  • Screening Choice: If a patient has received the BCG vaccine, IGRA is preferred over TST for screening purposes; also use IGRA in immunocompromised patients (e.g., transplant recipients).
  • TB Diagnosis Distinction: Neither TST nor IGRA can differentiate between active and latent TB infection; this distinction requires clinical correlation with symptoms, CXR findings, and microbiological testing.
  • Latent TB Criteria: Requires three conditions: 1) Positive TST/IGRA, 2) Negative chest X-ray (CXR), and 3) Absence of systemic TB manifestations (e.g., cough, fever). Treatment is typically Isoniazid for 9 months + Vitamin B6.
  • Active TB Diagnosis: Requires clinical symptoms (cough, hemoptysis, night sweats, etc.) AND CXR findings AND positive sputum culture/PCR. The gold standard remains sputum culture.
  • MAC Infection Clues: In non-HIV patients, suspect MAC infection if the patient is an elderly, thin white female with a connective tissue disorder and signs of chronic lung disease (e.g., pectothorax, scoliosis). Treatment involves Macrolides (Erythromycin/Clarithromycin).
  • TB Meningitis CSF: Characteristically shows high opening pressure, elevated protein, predominantly lymphocytic pleocytosis, and low glucose. PCR is the best diagnostic test.

Learning objectives

  • Differentiate the appropriate use of TST versus IGRA based on patient history (e.g., BCG status, immunocompromised state).
  • Establish the diagnostic criteria for Latent TB Infection (LTBI) vs. Active Tuberculosis Disease.
  • Identify key clinical and radiological findings suggestive of MAC infection in non-HIV patients.
  • Interpret CSF parameters to support a diagnosis of TB meningitis.
  • Select appropriate prophylactic monitoring tests before starting first-line anti-TB regimens (e.g., Pyrazinamide, Ethambutol).

Board exam buzzwords

ConditionKey FindingAssociationBoard Exam Tip
MAC InfectionOld white female; connective tissue disorder; chronic lung diseaseMycobacterium avium complexAlways suspect MAC in this specific demographic group. Treat with Macrolides (Erythromycin/Clarithromycin).
Latent TBPositive TST/IGRA + Negative CXR + No symptomsIsoniazid for 9 months + Vitamin B6Remember the three criteria are mandatory for diagnosis and treatment initiation.
Active TB MeningitisHigh CSF opening pressure, high protein, lymphocytosis, low glucosePCR of CSF (best test)The combination of these findings strongly points to TB meningitis; treat with IV anti-TB agents.
Pyrazinamide ToxicityHyperuricemia/Gout flarePyrazinamide (PZA)Always check uric acid levels before starting PZA therapy.

Rapid review table

TopicKey PointContextExam Relevance
TB ScreeningIGRA preferred over TSTPatient received BCG vaccine or is immunocompromised.High-yield trap: Never rely on TST/IGRA alone to differentiate active vs latent TB.
Latent TB TreatmentINH for 9 months + B6Standard regimen for LTBI in the US (MBM focus).Know the specific duration and required co-supplementation (B6) for high-yield recall.
Active TB DiagnosisSputum culture is gold standard; PCR/NAAT are alternatives.Suspected active disease with symptoms and CXR findings.If smear is negative, do not rule out TB; proceed to culture or molecular testing.
MAC InfectionOld white female + connective tissue disorderChronic pulmonary infection in non-HIV patients.Classic presentation pattern that must be memorized for board questions.

Board-speak -> diagnosis

Board-speak / Vignette phraseDiagnosis / ConceptWhy it fits
A patient who recently immigrated from a country with high TB prevalence and has received the BCG vaccine requires screening. Which test is preferred?IGRA (Interferon Gamma Release Assay)IGRA is superior to TST in individuals with prior BCG vaccination, as BCG can cause false-positive TST results.
A patient presents with chronic cough, hemoptysis, and night sweats, along with a CXR showing cavitary lesions. The most appropriate initial diagnostic step is:Sputum culture (Acid-Fast Bacilli)Active TB requires symptomatic presentation plus radiographic evidence; the gold standard for diagnosis remains sputum culture.
A patient has a positive TST/IGRA but no symptoms and a normal CXR. This clinical picture suggests:Latent Tuberculosis Infection (LTBI)Meeting these three criteria confirms LTBI, which is treated prophylactically with INH + B6.
An elderly woman with rheumatoid arthritis and chronic lung disease presents with signs of disseminated infection. Which organism should be suspected?Mycobacterium avium complex (MAC)MAC commonly affects immunocompromised patients (especially those with underlying connective tissue disorders) and is a classic board-exam association.
A patient with suspected TB meningitis has CSF analysis showing high opening pressure, elevated protein, and predominantly lymphocytic pleocytosis. What is the best diagnostic test?CSF PCR (Nucleic Acid Amplification Test)While AFB smear can be done, PCR offers higher sensitivity for diagnosing TB in the cerebrospinal fluid.
Before initiating therapy with Pyrazinamide, what laboratory value must be monitored due to potential toxicity?Uric acid levelsPyrazinamide is known to precipitate hyperuricemia and trigger gout flares; pre-treatment monitoring is mandatory.

Differential diagnosis / distinguishing features

MAC Infection vs. Other Pneumonia

Key FeaturesDistinguishing FindingsNext Step
Elderly, thin white female; connective tissue disorder; chronic lung disease/pectothorax.Acute onset symptoms; lack of underlying systemic illness or specific risk factors.If MAC suspected: Treat empirically with Macrolides (e.g., Clarithromycin).

Management pearls

  • Isolation: A patient can be released from isolation only after being on adequate anti-TB therapy for at least 14 days AND providing three consecutive negative AFB sputum smears.
  • Sputum Collection: For suspected active TB, collect induced sputum samples and subject them to AFB smear, culture (gold standard), and PCR/NAAT testing.
  • Drug Monitoring: Before starting Pyrazinamide, check serum uric acid levels due to the risk of precipitating gout. Before Ethambutol, perform a thorough ophthalmologic exam (visual acuity, color vision).
  • LTBI Treatment: The preferred regimen for LTBI in the US is Isoniazid for 9 months plus Vitamin B6 supplementation.

Don't miss

🚨
The Gold Standard: Sputum culture remains the gold standard for diagnosing active TB.
🚨
BCG Rule: When TST and IGRA are both options, choose IGRA if the patient has received the BCG vaccine or is immunocompromised.
🚨
MAC Triad: Remember the classic triad: old white female + connective tissue disorder + chronic lung disease/pectothorax.
🚨
TB Meningitis CSF: The combination of high opening pressure, elevated protein, and lymphocytosis strongly suggests TB meningitis; use PCR for diagnosis.

Integration & clinical reasoning

  • Infectious Disease: This episode integrates concepts from microbiology (Mycobacteria), immunology (T cell response measured by IGRA/TST), and pulmonology (CXR findings).
  • Rheumatology/Connective Tissue Disease: The association between MAC infection and connective tissue disorders highlights the systemic nature of chronic infections.
  • Pharmacology: Understanding drug toxicity monitoring (PZA -> Gout; EMB -> Optic Neuritis) is crucial for safe anti-TB therapy.

Concept connections / cross-references

  • For general infectious disease principles, review [ Episode 12 ] on fungal and bacterial pathogens.
  • For detailed information on autoimmune diseases and connective tissue disorders, see [ Episode 45 ].
  • For comprehensive coverage of pulmonary imaging findings (e.g., miliary pattern), refer to [ Episode 88 ].

High-yield association table

ConditionAssociationMechanismClinical Significance
MAC InfectionConnective Tissue Disease + Old White FemaleChronic inhalation/dissemination in immunocompromised hosts.High suspicion required for MAC; treatment with macrolides is necessary.
Pyrazinamide (PZA)Hyperuricemia / GoutPZA metabolism increases uric acid production.Mandatory pre-treatment monitoring of serum uric acid levels to prevent acute gout flares.
TB MeningitisCSF PCR testingHigh sensitivity for detecting Mycobacterium tuberculosis DNA in the cerebrospinal fluid.Best diagnostic test, especially when AFB smear is negative or inconclusive.
Ethambutol (EMB)Optic Neuritis / Visual DeficitCan cause dose-dependent optic neuropathy.Requires baseline and periodic ophthalmologic exams to monitor for visual changes.

Key terms glossary

TermDefinitionContextExample
IGRAInterferon Gamma Release AssayBlood test measuring T-cell response to TB antigens.Preferred screening tool in BCG-vaccinated or immunocompromised patients over TST.
MACMycobacterium avium complexGroup of non-tuberculous mycobacteria; common cause of chronic lung infection.Suspected in elderly, thin white women with underlying connective tissue disorders.
LTBILatent Tuberculosis InfectionEvidence of prior TB exposure without active disease (positive test + negative CXR/symptoms).Treated prophylactically with INH for 9 months + B6.
PectothoraxCongenital chest wall defect; abnormal rib cage structure.Associated with chronic lung infections and MAC colonization.A physical finding that, combined with other risk factors, suggests MAC infection.

Study optimization

TopicStudy ApproachPriorityResources
TB Screening/DiagnosisMaster the criteria for LTBI vs. Active TB; memorize TST/IGRA rules.High (Must know all three steps: Test, CXR, Symptoms).Review board-style vignettes focusing on differential diagnosis and screening choice.
Anti-TB Drug MonitoringCreate a quick reference chart of drug toxicity and required pre-treatment labs.Medium-High (Common trap question area).Focus on PZA -> Uric Acid; EMB -> Vision; RIF -> Liver function.
MAC InfectionMemorize the classic demographic triad and the appropriate antibiotic class.High (Specific, high-yield pattern recognition).Use mnemonics: "Old White Woman + Connective Tissue Disease = MAC."

Question pattern recognition

  • Pattern: Patient is immunocompromised or BCG vaccinated -> use IGRA for screening.
  • Pattern: Elderly white female with connective tissue disease and chronic lung symptoms -> suspect MAC infection (treat with Macrolides).
  • Pattern: Positive TST/IGRA, but no systemic symptoms and normal CXR -> diagnosis is Latent TB Infection (LTBI); treatment is INH for 9 months + B6.

Test yourself

Common mistakes to avoid

🚫
Mistake 1: Confusing Active vs. Latent TB. Never assume a positive TST/IGRA means active disease; always correlate with symptoms and CXR findings.
🚫
Mistake 2: Mismanaging MAC Infection. Do not treat suspected MAC infection solely based on the presence of connective tissue disease; clinical suspicion is key, and macrolides are required.
🚫
Mistake 3: Ignoring Drug Toxicity Monitoring. Failing to check uric acid before PZA or visual acuity before EMB can lead to severe complications (gout/optic neuritis).

Common traps

⚠️
Trap 1: Assuming that a positive TST/IGRA is sufficient for diagnosis. Correction: Requires clinical correlation and exclusion of active disease signs.
⚠️
Trap 2: Believing that the BCG vaccine negates the need for screening. Correction: The vaccine complicates interpretation, making IGRA or careful history taking essential.
⚠️
Trap 3: Thinking that a negative AFB smear rules out TB. Correction: Always proceed with culture and PCR testing if suspicion remains high.

Original transcript with highlights

Original transcript with highlights

Okay, welcome. I am divine. This is episode 262 of the Divine Intervention Podcast. This podcast should be relatively short. It's the Clutch TV Podcast. And again, if you listen to this, you should pretty much be able to hopefully get all your TV questions right on the test. And again, just a reminder from the 21st to the 23rd of this month, that's the next week Monday to Wednesday. On the 21st, I have a test against strategies class on the 22nd and 23rd. I have a comprehensive step to seek your review class, right? So if you want more details on that, so you want to sign up, there's still a few spots remaining. Just shoot me an email via the website and then we'll go from there. Okay, let's jump right into it. So the thing is, if you suspect that a person has TB, right? Or if they need to get, if they are trying to get you to pick a diagnostic test for TB on your exam. Always like, if you want to like screen, right, let's put it this way, right? If you want to screen, you can do one of two things on your test, right? You can do the TB skin test or you can do the interferon gamma release assing. Either one is perfectly acceptable on exams, right? Either one is perfectly acceptable on exams. Now, let me tell you something. If they give you a specific situation where the person, right? So this is like one specific scenario, right? Usually they won't give you both as answer choices like, oh, TB skin test and the interferon gamma release assing.

But let me tell you one specific scenario, let me show you an exam, right? If they give you a scenario for a person that's coming from a foreign country, right? Like an immigrant or something, especially someone that came from a foreign country less than five years ago. And then they're trying to get you to screen that person for TB. And in the answer choice, you see an answer choice that says, especially if the person has got in the BCG vaccine, right? They'll throw in this thing. The person has got in the BCG vaccine. I want to screen the person for TB, the hotel, they'll give you an answer choice, they'll say, TB skin test. And then they give you another answer choice that says interferon gamma release assing. If you see that, big interferon gamma release assing, right? So the person has received the BCG vaccine back in the day. They give you both answer choices, the TB skin test of interferon gamma release assing. Take the answer choice that says to do the interferon gamma release assing, right? It's just more helpful in those people. Also, they give you a question where the person doesn't follow up with the physician regularly. The last time they saw the physicians like five years ago, something crazy, right? Those are the kinds of people you know, they will very likely not come back in 70 to 72 hours to have their TB skin test results read. For those people, administered interferon gamma release assing in those specific populations.

And the thing though, I will say though, is whether a person has got in the BCG vaccine or not, it doesn't matter. The TB skin test results are always interpreted the exact same way. They are always interpreted the exact same way. And again, don't forget your millimeters of duration for the TB skin test. So if a person, remember, five millimeters of duration is positive in a person that is, I think the big thing you want to keep in mind here is a person that is immunocompromised, right? A person that is immunocompromised, right? So what are examples of who is an immunocompromised? What are different veneers they can create on the test, right? Can be a person that has HIV, that's the classic one, right? But it can also be a little more exotic, especially on this new NBA me exams, right? It will give you something about a person that has had a transplant of some sort and the person is an immunosuppression, right? Or the person is getting like chronic pregnancy therapy for some autoimmune disease, right? Or if you're a person that recently contacted someone that is known to have active TB, you definitely fall under that five millimeter in duration category, right? And then the 10 millimeters of duration, right? This one are, I think of like, high risk people and people in groups, right? So high risk people and people in groups, what do I mean by that? So let's say you're an immigrant and you just came from a foreign country again less than five years ago.

That's usually like the cut off, right? If you're an IV drug user, right? You fall in this 10 millimeter category, right? If you're a person that lives in a crowded environment, right? Prison, jail, right? Nursing home, right? Hospital person, something like that, right? Those people also again go that 10 millimeter category and again, if you're a healthcare worker, right? If you're a healthcare worker, you definitely fall within this 10 millimeter purview, right? And then 15 millimeters is positive in every person, right? It's positive in every person. Now, one thing I want to say is, and again, unfortunately, you do actually need to commit this stuff to memory, right? Now, let me tell you one thing right over the bat. You can never, if you remember this really, you'll see from a lot of pain and heartache on your test, you can never differentiate between active TB and latent TB by virtue of a TB skin test, one interferon gamma release assay. Fix this fact in your mind permanently. You can absolutely never differentiate between active TB or latent TB by a TB skin test, one interferon gamma release assay, right? Now, one thing I would say here is, really, there are two diagnoses of TB you want to essentially make on your test. You want to make the diagnosis of a person having active TB or a person having latent TB, because those people get different kinds of treatment, right? So, for example, if a person has latent TB, they need to meet three conditions on an MBM exam.

I'll say this again, for a person to be diagnosed with latent TB, they need to meet three conditions on an MBM. One, they must have a positive TB skin test or interferon gamma release assay. That's criteria one, they must have a positive TB skin test or a positive interferon gamma release assay. That's one, two, the chest x-ray must be negative. Three, they must not have any systemic manifestations of TB. They shouldn't be having cough, he might twist, we could also need that crap, okay? They need to meet those three criteria to be diagnosed with latent TB on an MBM. For a person who has latent TB on an MBM, guess what? You treat it with this regimen. This is the regimen that will probably cover 99% of your basis. But just for completeness sake, I'll talk about the other regimen, right? The primary regimen used on an MBM exam for latent TB is isozonaiazid for nine months. I don't care what you read in another Q-Bank or whatever, right? This is what the MBM goes after. Isozonaiazid for nine months plus vitamin B6, right? Isozonaiazid plus B6 for nine months, right? But one other thing you can do in some select cases, right? Especially people that don't have like HIV or you know, pretty normal people. You can actually do isozonaiazid for six months plus B6, right? You can even do rifamping for four months, just straight up rifamping for four months or INH for six months. But usually people that I you know compromise HIV folks, you do that nine months of INH plus B6.

But again, with that said, on an MBM exam, what I want you to pick, which will be correct like 99.9% of the time isozonaiazid for nine months plus vitamin B6, right? And then what tells you that the person has active TB, right? It's going to be a person that again has symptoms, right? The big, big, big thing is symptoms, right? Cough, right? Chess pain, hemoptysis, right? Fever chills, night sweats, those B symptoms. And they will have you for a long period of time, right? It can be like a TSA agent, it can be a person that is an immigrant, right? Or it can be a person that just traveled out of the country recently, like you know, over the last couple months or couple years and just came back not too long ago, right? Those people can have active TB, right? Those people can have active TB. And in general, if you suspect the person has active TB, right? You know, you typically want to do, you want to get something, you want to get some kind of sputum, right? You can do a bronchi of Yolala Vash to get that sputum, we can do an induced sputum sample, right? You can do an induced sputum sample, right? And typically when you do that, right, you're going to subject that sputum sample to the AFB smear, right? Like the acid phosphacylysmear, right? You're going to culture those things, right? In fact, remember, if you have a negative AFB smear, it doesn't roll out TB, right? Remember the gold standard for diagnosing TB, believe it or not, is actually a sputum culture, right?

But it takes weeks for TB to grow, right? It takes weeks for TB to grow, right? It takes weeks for TB to grow. And one thing I would say is, if for some reason they give you a question about a person that has a negative AFB smear, right? And they say for your next best step, right? And you don't see an answer that says to do a culture, go ahead and do like PCR testing, right? You know, the another thing for PCR and NV Me exams, right, is NEAT, right? Like a nucleic acid amplification test. Go ahead and do that on the sputum to diagnose a TB, right? To diagnose a TB, right? And how do we treat active TB? Easy, right? Active TB will usually treat it, right, with a combination of ripe, right? So, right, fanping, isonize it, pair of xenomite and ethambutol, right? You give these four agents plus vitamin B6 for the first two months. And then after that, for the remaining four months, because these six months of therapy total, right? So, first two months, right, fanping isonize it, pair of xenomite and ethambutol, right? Plus B6 for two months, and then for the remaining four months, you give right, fanping and isonize it, plus B6. Basically, whenever you're on a sonyis it, you've got to be on B6, right? You've got to be on B6, okay? And one weird, bizarre thing that your friends at the NV Me are beginning to go after these days, they're beginning to worry, especially again, the newer exams, right? There are some weird things they are beginning to touch on these days, right?

So, like, for example, right, like, you don't want you to know criteria that means that, oh, this person no longer has infection, you know, they can be exposed to other human beings, even if they are still being treated. Obviously, you're not going to be quarantined that person for a month, right? That's ridiculous, right? So, basically, you must have been on adequate therapy for two weeks, for at least 14 days, right? Just kind of think of the coronavirus guidelines, right? Like, oh, be quarantined for two weeks, right? And you see the person is getting clinically better, right? And then, they must have had, like, three negative sputum smears, right? Like, consecutive sputum smears, AFB smears, three must be negative. You need to meet those criteria for you to say, okay, this person doesn't need to be pleased in quarantine, this person doesn't need to be isolated anymore. We can go ahead and let this person out into the wild, right? Now, some preventive medicine things that they love to test on exams, right? Are things you're supposed to do before you start certain TB regimens, right? So, the thing is, before you start putting a person on parasyneamide, you need to check their levels of urethaceptic, right? Because remember, parasyneamide can trigger gout, right? It can trigger gout. That's one of those weird, high-yield things you want to know, right?

And then, people that have been studied on a thambutal, remember, those people need some kind of ophthalmologic testant, right? So, you need to check their visual acuity, check for call, check their color vision and all that stuff, right? Before you start them on a thambutal, right? Just one of those weird, bizarre things. You want to keep in mind, for example, right? Then remember, TB can, many times on in-beaming exams, if you show you a chest x-ray or TB, you can see the cavitary lesion, right? The person can have like a unilateral plural of fusion, right? Remember, people can also have like, like unilateral hyalurgylomyphadenopathy, right? They can even have this miliary TB, right? Where you see all these dots, right? In their, in their, in their lungs, right? These are things you'll want to be able to identify on imaging, on an NBME, on an NBME exam, right? Those are things you'll want to be able to identify. And then remember, TB can also cause problems in the brain, right? Like TB meningitis, right? Remember, people that have TB meningitis, you check the CSF, right? The CSF, classically, right? The thing that will happen is, you'll notice that they have a ton, like, elevated, very, very elevated pressures, right? So, high CSF opening pressures, you see a ton on an lymphocyte, right? So, the white cells will be up, proteins will be up, proteins will be up, and the white cells will be predominantly lymphocytes, right?

And again, the way you treat TB meningitis is exactly where you treat a regular TB, right? And again, remember, the glucose will be low, protein will be high, stuff like that, right? And usually, the way you treat, the way you diagnose, the way you deal with that CSF, where you suspect the person has TB meningitis, is to just do PCR of the CSF. That's actually the best test in diagnosing a TB meningitis. But if they say, do an AFB smear of the CSF, that's also acceptable on NBME exams as well, right? And then, don't forget that TB can also cause osteomyelitis, right? So, if they tell you about a person that has, like, back pain, right? And they have all these TB risk factors, right? Think about POTS disease, right? Remember, TB can cause a vertebral kind of osteomyelitis, right? It can cause a vertebral kind of osteomyelitis. And then one last thing I want to say, I guess, that may help you on an exam with regards to these microbiota-term species, right? Don't forget microbiota-term avium, right? Again, remember, if your CD4 count is less than 50, back in the day, we used to prophylax against those, but we don't do that anymore, right? Mac prophylaxis is no longer recommended, right? But the thing is, Mac can show up in non-HIV people on NBME exams, right? And usually, it'll be the classic presentation, right, of Mac in a non-HIV person, on especially the newer NBME exam, right? It'll be like an old woman, old white female, right? Very thin, right?

And they'll usually have something that tells you that they have, like, a connective tissue thing going on, right? Or they may have, like, some chest wall anomaly, right? They can have, like, pectosexcavaron, they can have, like, scoliosis. Or if you see a person that has, like, TB-stalk symptoms, and the person has my trovault prolapse, I want you to think about a Mac infection. And really, the way we treat Mac infections on exams is with macrolets, right? So, you treat Mac with a macrolet, right? So, you can give them, like, erythromycin, clarythromycin, or whatever, right? Make sure those people's cutie intervals are not super prolonged, right? Make sure they're cutie intervals are not super prolonged. Okay, so I'm going to go ahead and stop here. Please subscribe to this podcast. It's an Apple podcast. It's on Google, please, on Spotify, please subscribe. I also have a You Tube channel, Divine Intervention, USM-Eli podcast, and videos. And then, also have a website, right? Divine Intervention Podcast.com. So, please subscribe. I wish you all the very best. Thank you for listening. Thank you for all the support. And God bless you. Have a wonderful weekend. I'll see you next time.

Practice questions — USMLE style

Question 1 — Infectious Disease

A 35-year-old immigrant, who received the BCG vaccine in childhood, presents for routine screening for tuberculosis (TB). The physician needs to determine the most appropriate diagnostic test given the patient's history and current clinical status. Which of the following tests is preferred over a standard Tuberculin Skin Test (TST) in this specific scenario?

  • A) Acid-Fast Bacilli (AFB) smear analysis of sputum
  • B) Tuberculin Skin Test (TST) reading at 48–72 hours
  • C) Interferon Gamma Release Assay (IGRA)
  • D) Chest X-ray for evidence of cavitary lesions

Answer: C. The transcript emphasizes that if a patient has received the BCG vaccine, and both TST and IGRA are available as options, the IGRA is preferred. While TST results are always interpreted the same way regardless of BCG status, the IGRA is considered more helpful in individuals who have been vaccinated with BCG because the vaccine can cause false positives or atypical reactions on the TST.

Question 2 — Preventive Medicine

A healthcare worker (HCW) from a crowded environment presents for TB screening. The patient has no known risk factors other than occupation and living conditions, but they are considered high-risk due to their exposure potential. According to current guidelines, what is the appropriate interpretation cutoff threshold for this individual's TST?

  • A) 5 millimeters of induration
  • B) 10 millimeters of induration
  • C) 15 millimeters of induration
  • D) The test should be deferred until a chest X-ray is performed

Answer: B. The transcript details that the 10 mm cutoff applies to high-risk groups, including healthcare workers, IV drug users, and those living in crowded environments (e.g., jail, nursing home). While 5mm is for immunocompromised individuals, and 15mm is positive in every person, the HCW falls squarely into the 10mm category.

Question 3 — Infectious Disease

A patient is diagnosed with latent tuberculosis infection (LTBI) based on clinical criteria. The physician determines that the patient does not have active symptoms or signs of TB disease. Which regimen represents the standard primary treatment for LTBI in a non-HIV immunocompetent adult, according to board examination guidelines?

  • A) Rifampin monotherapy for 4 months
  • B) Isoniazid plus Pyrazinamide for 9 months
  • C) Isoniazid (INH) plus Vitamin B6 for 9 months
  • D) Ethambutol and Prothionamide combination therapy for 6 months

Answer: C. The transcript specifies that the primary regimen taught for LTBI on board exams is Isoniazid (INH) combined with Vitamin B6 for a total duration of nine months. While other regimens exist (e.g., rifampin for 4 months), INH + B6 for 9 months is the high-yield answer expected on USMLE/NBME examinations.

Question 4 — Neurology

A patient presents with chronic back pain and has a history of multiple risk factors, including immunosuppression and recent travel to an endemic area. CSF analysis is performed due to suspicion of central nervous system involvement from TB. Which combination of findings would be most characteristic of tuberculous meningitis?

  • A) Low protein level, high glucose, and predominant neutrophils
  • B) High opening pressure, low protein, and predominantly eosinophils
  • C) Elevated white blood cell count with a predominance of lymphocytes, elevated protein, and low glucose
  • D) Normal CSF composition with positive AFB smear only

Answer: C. The transcript describes the classic findings for TB meningitis in the CSF: high opening pressures, elevated proteins, and a predominant lymphocytic pleocytosis. Furthermore, it notes that the glucose level is typically low. These findings are crucial for differential diagnosis of CNS infections.

Quick fire review

What are the three necessary criteria required to diagnose Latent TB Infection (LTBI)?

1) Positive TST or IGRA; 2) Negative chest X-ray; and 3) Absence of systemic symptoms (e.g., cough, fever).

Which diagnostic test is considered the gold standard for confirming active Tuberculosis?

Sputum culture.

What are the classic CSF findings in a patient suspected of having TB Meningitis?

High opening pressure, predominantly lymphocytes, low glucose, and high protein.

If a person is starting Pyrazinamide (PZA), what specific metabolic abnormality must be checked first?

Urate levels, because PZA can trigger gout.

What are the key risk factors that place an individual in the 10mm TST cutoff category?

IV drug use, living in crowded environments (prisons/nursing homes), or being a healthcare worker.

Which class of antibiotics is used to treat MAC infections, and what are two examples?

Macrobetol; Erythromycin or Clarithroam.

What test should be performed before starting Rifampin therapy?

An ophthalmologic examination (checking visual acuity and color vision).

For a patient with active TB, what is the standard initial combination drug regimen used for treatment?

RIPE + B6 (Rifampin, Isoniazid, Pyrazinamide, Ethambutol) plus Vitamin B6.

What specific finding on imaging suggests Miliary TB?

Multiple small dots scattered throughout the lungs.

If a patient has suspected MAC infection and is not HIV positive, what are two clinical signs that might prompt suspicion?

History of tracheal prolapse or symptoms resembling TB-stalk syndrome.

What diagnostic test is considered the best single test for diagnosing TB Meningitis?

PCR testing on the Cerebrospinal Fluid (CSF).

Quick recall / Anki-style questions

What test should be performed before starting Rifampin therapy?

An ophthalmologic examination (checking visual acuity and color vision).

For a patient with active TB, what is the standard initial combination drug regimen used for treatment?

RIPE + B6 (Rifampin, Isoniazid, Pyrazinamide, Ethambutol) plus Vitamin B6.

What specific finding on imaging suggests Miliary TB?

Multiple small dots scattered throughout the lungs.

If a patient has suspected MAC infection and is not HIV positive, what are two clinical signs that might prompt suspicion?

History of tracheal prolapse or symptoms resembling TB-stalk syndrome.

What diagnostic test is considered the best single test for diagnosing TB Meningitis?

PCR testing on the Cerebrospinal Fluid (CSF).